Symbol: |
FANCE
|
Description: |
Fanconi anemia, complementation group E [Source:HGNC Symbol;Acc:3586]
|
Location: |
Chr6:35420138-35434880[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:198
Gene |
Compound |
Gen_sig |
Exp_pattern |
FANCE |
NSC 49713 |
0.023 |
Down |
FANCE |
NSC 53454 |
0.031 |
Down |
FANCE |
3-BROMO-2,4,6-TRINITROTOLUENE |
0.016 |
Down |
FANCE |
NSC 600758 |
0.042 |
Down |
FANCE |
4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride |
0.047 |
Down |
FANCE |
Naphtho[2,1-b]furan-6,9-dione, 7-chloro-1,2-dihydro- 5-hydroxy-2-methoxy-2,4-dimethyl- |
0.006 |
Down |
FANCE |
4H-1-Benzothiopyran-4-one, 2-(methylsulfinyl)- |
0.025 |
Down |
FANCE |
4H-1-Benzothiopyran-4-one, 2-(methylsulfonyl)- |
0.002 |
Down |
FANCE |
14-FLUORO-4-DEMETHOXYDAUNORUBICIN |
0.038 |
Down |
FANCE |
ANTINEOPLASTIC-625543 |
0.032 |
Down |
FANCE |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(2-methoxy- phenyl)methylene]-, hydrochloride |
0.035 |
Down |
FANCE |
(E)Methyl-3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl) prop-2-enoate |
0.038 |
Down |
FANCE |
NSC 639211 |
0.008 |
Down |
FANCE |
Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)phenyl] ethylidene]-5-[(1-piperidinyl)methyl]-, hydrochloride |
0.045 |
Down |
FANCE |
Ethanedioic acid, mono(6-nitrobenzothiazol-2-yl)amide, mono[[2-(acetylhydrazino)-4-methylthiazol-5-yl]carbonyl] hydrazide |
0.046 |
Down |
Expression pattern: Sensitivity / Resistance
Total:14 Current:3
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:5
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:37
Total:3 Current:1
[First] [Prev]  Next Last 
|